Madrigal Pharmaceuticals (MDGL) is up 12.4%, or $38.58 to $349.72.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDGL:
- Madrigal patent for Rezdiffra ‘significant win,’ says Piper Sandler
- Madrigal Pharmaceuticals receives notice of allowance for Rezdiffra patent
- Short Report: Rocket Companies short interest at record high
- Madrigal Pharmaceuticals: Positive CHMP Opinion and Phase 3 Success Drive Buy Rating
- Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting